Evaluation of Sericin as a Fetal Bovine Serum-Replacing Cryoprotectant During Freezing of Human Mesenchymal Stromal Cells and Human Osteoblast-Like Cells

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F14%3A10210839" target="_blank" >RIV/00216208:11110/14:10210839 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11310/14:10210839 RIV/00216208:11140/14:10210839
Result on the web
<a href="http://dx.doi.org/10.1089/bio.2013.0078" target="_blank" >http://dx.doi.org/10.1089/bio.2013.0078</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1089/bio.2013.0078" target="_blank" >10.1089/bio.2013.0078</a>

Result language
angličtina
Original language name
Evaluation of Sericin as a Fetal Bovine Serum-Replacing Cryoprotectant During Freezing of Human Mesenchymal Stromal Cells and Human Osteoblast-Like Cells
Original language description
The replacement of FBS and DMSO in freezing medium of human cells was evaluated and sericin as the replacing agent was tested. It was found that sericin may substitute for FBS in primary MSC but cannot substitute for DMSO.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EB - Genetics and molecular biology
OECD FORD branch
—

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)